GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

105 hedge funds and large institutions have $57.4M invested in Sanofi Contingent Value Rights in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

33% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 15

Holders
105
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$591K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.37M
2
+$947K
3
+$190K
4
NGA
New Generation Advisors
Massachusetts
+$163K
5
JGC
J. Goldman & Co
New York
+$76K

Top Sellers

1
-$961K
2
-$560K
3
-$540K
4
Millennium Management
Millennium Management
New York
-$180K
5
WA
Whitebox Advisors
Minnesota
-$85.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$4K
52
$4K
53
$4K
54
$3K
55
$2.07K
56
$2K
57
$2K
58
$1K
59
$1K
60
$534
61
$385
62
$128
63
$49
64
$5
65
–
66
–
67
–
68
–
69
–
70
–
71
–
72
–
1 2
3